Register Financial Advisors’s AstraZeneca AZN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-180	Closed	-$28.1K	–	336
2024 Q2	$28.1K	Hold	180	–	–	0.01%	414
2024 Q1	$24.4K	Buy	+180	New	+$23.8K	0.01%	428
2023 Q4	–	Sell	-195	Closed	-$26.4K	–	328
2023 Q3	$26.4K	Buy	195 +15	+8%	+$2.05K	0.02%	315
2023 Q2	$25.8K	Hold	180	–	–	0.02%	319
2023 Q1	$25K	Hold	180	–	–	0.02%	313
2022 Q4	$24.4K	Buy	+180	New	+$22.6K	0.02%	489

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Register Financial Advisors's AZN Position: Q3 2024 in Review

Register Financial Advisors sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 180 shares — an estimated $28.1K sold.

Register Financial Advisors first reported a position in AZN in Q4 2022 and held it in 6 quarters. The position peaked at $28.1K in Q2 2024. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

Register Financial Advisors reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
Register Financial Advisors sold 180 AstraZeneca shares in Q3 2024, an estimated $28.1K.
Register Financial Advisors first reported a position in AstraZeneca in Q4 2022 and held it in 6 quarters.
Register Financial Advisors's AstraZeneca position peaked at $28.1K in Q2 2024.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Register Financial Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.